BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Daniel Grosslight does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 HCATHealth Catalyst Inc | Buy | $6.50 | Apr 2025 | −71.6% | Miss |
 AGLagilon health Inc | Buy | $5.00 | Apr 2025 | −79.0% | Miss |
 GDRXGoodrx Holdings Inc | Buy | $6.25 | Jan 2025 | −45.0% | Miss |
| GDRXGoodrx Holdings Inc | Buy | $7.00 | Nov 2024 | −40.3% | Miss |
| GDRXGoodrx Holdings Inc | Buy | $10.00 | Aug 2024 | −37.4% | Miss |
 CORCencora Inc. | Buy | $195.00 | May 2023 | +28.4% | Hit |
| CORCencora Inc. | Buy | $185.00 | Mar 2023 | +37.6% | Hit |
 SLQTSelectquote Inc | Buy | $20.00 | Sep 2021 | −81.4% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.